Dermapharm Holding SE (FRA:DMP)

Dermapharm Holding SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	162.69	121.31	158.72	151.02	161.41	120.3
Short-Term Investments	-	0.59	0.82	1.48	1.76	2.52
Cash & Short-Term Investments	162.69	121.9	159.54	152.5	163.18	122.82
Cash Growth	-1.86%	-23.60%	4.62%	-6.54%	32.85%	5.80%
Accounts Receivable	117.56	102.18	95.41	96.72	72.52	55.52
Other Receivables	0.86	11.25	40.39	8.41	14.29	6.21
Receivables	118.42	113.43	135.8	105.13	86.81	61.72
Inventory	350.32	343.38	320.76	255.72	243.6	205.73
Prepaid Expenses	-	7.6	7.94	7	13.19	3.45
Other Current Assets	31.16	7.19	6.45	13.6	12.45	6.33
Total Current Assets	662.59	593.5	630.5	533.95	519.22	400.05
Property, Plant & Equipment	314.6	315.03	330.77	225.67	222.29	199.62
Long-Term Investments	20.92	21.87	25.06	36.57	105.62	60.7
Goodwill	576.27	576.38	578.52	271.32	264.73	266.27
Other Intangible Assets	497.25	406.14	441.61	212.12	217.13	235.24
Long-Term Deferred Charges	-	106.18	103.25	92.92	77.72	62.1
Other Long-Term Assets	63.92	0.94	0.97	0.28	0.27	0.41
Total Assets	2,136	2,080	2,161	1,413	1,407	1,224
Accounts Payable	100.74	94.79	86.64	56.1	52.1	50.37
Accrued Expenses	-	67.69	94.35	54.51	45.17	38.82
Short-Term Debt	0.01	0.04	0.01	0	-	-
Current Portion of Long-Term Debt	78.85	86.04	111.43	1.87	2.38	22.21
Current Portion of Leases	5.75	5.12	5	3.02	3.2	3.84
Current Income Taxes Payable	34.81	58.83	81.82	96.35	48.8	8.85
Current Unearned Revenue	-	1.5	1.43	0.56	0.62	1.06
Other Current Liabilities	140.14	12.91	13.82	5.38	3.35	7.72
Total Current Liabilities	360.29	326.92	394.49	217.79	155.61	132.87
Long-Term Debt	910.93	886.71	963.89	501.84	565.71	570.48
Long-Term Leases	14.02	12.35	13.25	9.72	9.01	10.28
Long-Term Unearned Revenue	-	11.34	11.69	9.2	9.46	9.72
Long-Term Deferred Tax Liabilities	110.42	111.7	112.39	50.52	36.06	29.95
Other Long-Term Liabilities	13.86	3.08	2.71	1.99	2.41	1.77
Total Liabilities	1,530	1,472	1,616	880.34	907.14	899.81
Common Stock	53.84	53.84	53.84	53.84	53.84	53.84
Retained Earnings	437.8	433.19	367.22	355.36	337.95	177.08
Comprehensive Income & Other	116.61	117.39	118.14	122.4	105.52	91.04
Total Common Equity	608.25	604.42	539.21	531.59	497.32	321.97
Minority Interest	-2.76	3.87	5.84	0.9	2.52	2.62
Shareholders' Equity	605.49	608.3	545.05	532.49	499.83	324.58
Total Liabilities & Equity	2,136	2,080	2,161	1,413	1,407	1,224
Total Debt	1,010	990.26	1,094	516.45	580.3	606.8
Net Cash (Debt)	-846.87	-868.36	-934.03	-363.95	-417.13	-483.98
Net Cash Per Share	-15.75	-16.13	-17.35	-6.76	-7.75	-8.99
Filing Date Shares Outstanding	53.57	53.84	53.84	53.84	53.84	53.84
Total Common Shares Outstanding	53.57	53.84	53.84	53.84	53.84	53.84
Working Capital	302.29	266.58	236.01	316.16	363.61	267.18
Book Value Per Share	11.35	11.23	10.01	9.87	9.24	5.98
Tangible Book Value	-465.27	-378.1	-480.92	48.15	15.46	-179.54
Tangible Book Value Per Share	-8.68	-7.02	-8.93	0.89	0.29	-3.33
Land	-	247.87	252.54	171.75	163.41	147.52
Machinery	-	252.92	234.8	178.45	163.77	137.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.